These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

555 related items for PubMed ID: 21867996

  • 1. Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer.
    Briggs RH, Chowdhury FU, Lodge JP, Scarsbrook AF.
    Clin Radiol; 2011 Dec; 66(12):1167-74. PubMed ID: 21867996
    [Abstract] [Full Text] [Related]

  • 2. The role of FDG PET/CT in patients with colorectal cancer metastases.
    Kochhar R, Liong S, Manoharan P.
    Cancer Biomark; 2010 Dec; 7(4):235-48. PubMed ID: 21576816
    [Abstract] [Full Text] [Related]

  • 3. [Impact of positron emission tomography on clinical management of potentially resectable non-small-cell lung cancer: a French prospective multicenter study].
    Margery J, Milleron B, Vaylet F, Grahek D, Lebeau B, Mangiapan G, Bonardel G, de Labriolle-Vaylet C, Meignan M, Carette MF, Talbot JN, Housset B.
    Rev Pneumol Clin; 2010 Oct; 66(5):313-20. PubMed ID: 21087727
    [Abstract] [Full Text] [Related]

  • 4. Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
    Yao J, Gan G, Farlow D, Laurence JM, Hollands M, Richardson A, Pleass HC, Lam VW.
    ANZ J Surg; 2012 Mar; 82(3):140-4. PubMed ID: 22510123
    [Abstract] [Full Text] [Related]

  • 5. Impact of Fluorodeoxyglucose PET/Computed Tomography on the Management of Patients with Colorectal Cancer.
    Laurens ST, Oyen WJ.
    PET Clin; 2015 Jul; 10(3):345-60. PubMed ID: 26099671
    [Abstract] [Full Text] [Related]

  • 6. The influence of FDG PET-CT on the detection of extrahepatic disease in patients being considered for resection of colorectal liver metastasis.
    Lake ES, Wadhwani S, Subar D, Kauser A, Harris C, Chang D, Lapsia S.
    Ann R Coll Surg Engl; 2014 Apr; 96(3):211-5. PubMed ID: 24780786
    [Abstract] [Full Text] [Related]

  • 7. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.
    Brush J, Boyd K, Chappell F, Crawford F, Dozier M, Fenwick E, Glanville J, McIntosh H, Renehan A, Weller D, Dunlop M.
    Health Technol Assess; 2011 Sep; 15(35):1-192, iii-iv. PubMed ID: 21958472
    [Abstract] [Full Text] [Related]

  • 8. Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.
    Ng SP, David S, Alamgeer M, Ganju V.
    Int J Radiat Oncol Biol Phys; 2015 Sep 01; 93(1):111-7. PubMed ID: 26279029
    [Abstract] [Full Text] [Related]

  • 9. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.
    Interact Cardiovasc Thorac Surg; 2010 Jun 01; 10(6):1009-14. PubMed ID: 20197344
    [Abstract] [Full Text] [Related]

  • 10. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
    Mertens LS, Fioole-Bruining A, Vegt E, Vogel WV, van Rhijn BW, Horenblas S.
    BJU Int; 2013 Oct 01; 112(6):729-34. PubMed ID: 23790129
    [Abstract] [Full Text] [Related]

  • 11. 18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma.
    Ardito A, Massaglia C, Pelosi E, Zaggia B, Basile V, Brambilla R, Vigna-Taglianti F, Duregon E, Arena V, Perotti P, Penna D, Terzolo M.
    Eur J Endocrinol; 2015 Dec 01; 173(6):749-56. PubMed ID: 26346137
    [Abstract] [Full Text] [Related]

  • 12. Optimizing the role of FDG PET-CT for potentially operable metastatic colorectal cancer.
    Culverwell AD, Chowdhury FU, Scarsbrook AF.
    Abdom Imaging; 2012 Dec 01; 37(6):1021-31. PubMed ID: 22371087
    [Abstract] [Full Text] [Related]

  • 13. Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases.
    Truant S, Huglo D, Hebbar M, Ernst O, Steinling M, Pruvot FR.
    Br J Surg; 2005 Mar 01; 92(3):362-9. PubMed ID: 15672427
    [Abstract] [Full Text] [Related]

  • 14. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
    Manohar K, Mittal BR, Senthil R, Kashyap R, Bhattacharya A, Singh G.
    Nucl Med Commun; 2012 Jun 01; 33(6):591-6. PubMed ID: 22334135
    [Abstract] [Full Text] [Related]

  • 15. Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT.
    Wildi SM, Gubler C, Hany T, Petrowsky H, Clavien PA, Jochum W, Gerlach T, Fried M, Mullhaupt B.
    J Clin Ultrasound; 2008 Jan 01; 36(1):20-6. PubMed ID: 17937421
    [Abstract] [Full Text] [Related]

  • 16. Routine (18)F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making.
    Kantorová I, Lipská L, Bêlohlávek O, Visokai V, Trubaĉ M, Schneiderová M.
    J Nucl Med; 2003 Nov 01; 44(11):1784-8. PubMed ID: 14602860
    [Abstract] [Full Text] [Related]

  • 17. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
    Cuellar SL, Carter BW, Macapinlac HA, Ajani JA, Komaki R, Welsh JW, Lee JH, Swisher SG, Correa AM, Erasmus JJ, Hofstetter WL.
    J Thorac Oncol; 2014 Aug 01; 9(8):1202-6. PubMed ID: 25157774
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of efficacy and clinical impact of FDG-PET in patients with suspicion of recurrent colorectal cancer].
    Borrego Dorado I, Gómez Camarero P, Ruiz Franco-Baux J, Vázquez Albertino R.
    Rev Esp Med Nucl; 2004 Aug 01; 23(5):313-23. PubMed ID: 15450136
    [Abstract] [Full Text] [Related]

  • 19. Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence.
    Deleau C, Buecher B, Rousseau C, Kraeber-Bodéré F, Flamant M, des Varannes SB, Frampas E, Galmiche JP, Matysiak-Budnik T.
    Eur J Gastroenterol Hepatol; 2011 Mar 01; 23(3):275-81. PubMed ID: 21304319
    [Abstract] [Full Text] [Related]

  • 20. Controversies in the management of colorectal liver metastases: role of PET and PET/CT.
    Wiering B, Vogel WV, Ruers TJ, Oyen WJ.
    Dig Surg; 2008 Mar 01; 25(6):413-20. PubMed ID: 19212113
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.